In 2013, the US Supreme Court ruled against one company owning the patent on genetic testing for BRCA1 and BRCA2 genes. Changes in these genes are associated with a high risk for breast cancer and ovarian cancer. The ruling cited that human genes are not eligible for patents because they are a product of nature. Since this ruling, the world of cancer genetic testing has opened up both scientifically and financially.
Cancer Education Blog
View All Categories
- Blood Cancer (1)
- Breast Cancer (12)
- Cancer Management (8)
- Cancer Prevention (14)
- Cancer Research (10)
- Cancer Risk (5)
- Cancer Screening (8)
- Cancer Survivorship (3)
- Cancer Treatment (6)
- Car T-Cell Therapy (1)
- Cervical Cancer (1)
- Colon & Rectal Cancer (4)
- Coronavirus (1)
- Genetic Testing (11)
- Gynecologic Cancer (4)
- Healthcare Providers (3)
- Immunotherapy (1)
- Lung Cancer (5)
- Lymphomas (1)
- Nutrition and Exercise (1)
- Ovarian Cancer (4)
- Prostate Cancer (8)
- Skin Cancer (8)
- Supportive Care (1)
- Survivorship and Family (2)
- Survivorship and Helping Others (2)
- Survivorship and Nutrition (2)
- Survivorship and Side Effects (1)
Genetic Testing: Personalized Medicine at its Best
February 16, 2018
Read More Categories: Ovarian Cancer, Breast Cancer, Cancer Screening, Genetic Testing, Colon & Rectal Cancer
Mammograms… Who Needs ‘em?
October 6, 2017
October is Breast Cancer Awareness Month, making it a great time to learn a little more about breast cancer screenings for yourself or a loved one. The information below will help you better understand why mammograms are important, other potential screening methods, when you should be screened, and what can be done if someone needs a mammogram but cannot afford one. This knowledge can help you be better informed so you can share it with others this October, as well as the rest of the year.
Read More Categories: Breast Cancer, Cancer Screening